Scienion GmbH – Trademark Portfolio

Entity Type: 98

Scienion GmbH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PROTEOONE.

Volmerstr. 7b

12489 Berlin

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Scienion GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Scienion GmbH have?

Scienion GmbH has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Scienion GmbH file in?

Scienion GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Scienion GmbH's most well-known trademarks?

Scienion GmbH's registered trademark portfolio includes well-known marks such as PROTEOONE. These are among 1 currently registered trademark in the portfolio.

What is Scienion GmbH's trademark registration success rate?

Scienion GmbH has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.